home / stock / htgm / htgm news

HTGM News and Press, HTG Molecular Diagnostics Inc. From 10/26/22

Stock Information
Company Name: HTG Molecular Diagnostics Inc.
Stock Symbol: HTGM
Market: NASDAQ
Website: htgmolecular.com
Menu
HTGM HTGM Quote HTGM Short HTGM News HTGM Articles HTGM Message Board
Get HTGM Alerts

News, Short Squeeze, Breakout and More Instantly...
HTGM - HTG to Collaborate With OmiCure, Providing Transcriptomic Data Across Several Cancer Indications

TUCSON, Ariz. and PARIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, and OmiCure ® , a leading European digital health com...
HTGM - HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., Oct. 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, completed its planned milestones for the third quarter of 2022, further ...

HTGM - HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

TUCSON, Ariz., Sept. 26, 2022 (GLOBE NEWSWIRE) --  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate in the Cantor Fi...

HTGM - The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test

TUCSON, Ariz., Sept. 20, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that the Fundación Instituto Valenciano de Oncologí...
HTGM - HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2022 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) Q2 2022 Earnings Conference Call August 11, 2022, 16:30 ET Company Participants Andrew Eriksen - LifeSci Advisors John Lubniewski - President, CEO & Director Shaun McMeans - SVP, CFO, Secretary & Treasurer Conf...

HTGM - HTG Molecular Q2 GAAP loss per share widens, revenue down

HTG Molecular press release ( NASDAQ: HTGM ): Q2 GAAP EPS of -$0.54 (vs. -$0.39 Y/Y). Revenue of $1.5M (-28.6% Y/Y). For further details see: HTG Molecular Q2 GAAP loss per share widens, revenue down

HTGM - HTG Molecular Diagnostics Reports Second Quarter 2022 Results

TUCSON, Ariz., Aug. 11, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business highlights and financial results for...
HTGM - HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarte...

HTGM - Snowflake, Oatly Group among premarket losers' pack

Eliem Therapeutics ELYM -25% on report to discontinue development of lead asset as mid-stage pain trial fails . Mobile Global Esports (MGAM) -14% . Senti Biosciences ( SNTI ) -10% . Celyad Oncology ( CYAD ) -11% . Eos Energy Enterprises EOSE...

HTGM - Cytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization Investments

Cytek and 10x Genomics both offer single cell visualization tools, a growing and important field in modern medicine. However, each company sees huge differences in popularity, financial performance, and valuation, leading to a significant difference in outlook. This article will c...
Previous 10 Next 10